Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Peerlinck

Showing results (51-60 of 82) with videos related to

Pageof 9
Sort By:
Thrombosis and Haemostasis|January 1, 1997
Factor VIII inhibitors in previously treated haemophilia A patients with a double virus-inactivated plasma derived factor VIII concentrateK Peerlinck, J Arnout, M Di Giambattista, et al.
Blood|December 1, 1994
Molecular basis for type 1 antithrombin deficiency: identification of two novel point mutations and evidence for a de novo splice site mutationK Jochmans, W Lissens, T Yin, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 10, 2017
Deficits of ankle muscle strength not found in children, adolescents and young adults with haemophilic ankle arthropathyS Lobet, J-L Croisier, A-C Lantin, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 24, 2016
Hepatitis G viral RNA in serum and in peripheral blood mononuclear cells and its relation to HCV-RNA in patients with clotting disordersL Sheng, A Soumillion, K Peerlinck, et al.
Journal of Thrombosis and Haemostasis : JTH|May 1, 2012
Antidote strategies to reverse anticoagulation with TB-402, a long-acting partial inhibitor of factor VIIIM Tangelder, C Long, J Emmerechts, et al.
British Journal of Haematology|March 1, 1992
A patient with von Willebrand's disease characterized by a compound heterozygosity for a substitution of Arg854 by Gln in the putative factor-VIII-binding domain of von Willebrand factor (vWF) on one allele and very low levels of mRNA from the second vWF alleleK Peerlinck, J C Eikenboom, H K Ploos Van Amstel, et al.
Thrombosis and Haemostasis|May 1, 1997
Hepatitis G viral RNA in serum and in peripheral blood mononuclear cells and its relation to HCV-RNA in patients with clotting disordersL Sheng, A Soumillion, K Peerlinck, et al.
Circulation|October 1, 1993
MK-383 (L-700,462), a selective nonpeptide platelet glycoprotein IIb/IIIa antagonist, is active in manK Peerlinck, I De Lepeleire, M Goldberg, et al.
International Journal of Laboratory Hematology|March 25, 2018
The adsorption of dabigatran is as efficient as addition of idarucizumab to neutralize the drug in routine coagulation assaysM Jacquemin, J Toelen, L Feyen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 5, 2013
Comparing normal saline versus diluted heparin to lock non-valved totally implantable venous access devices in cancer patients: a randomised, non-inferiority, open trialG A Goossens, M Jérôme, C Janssens, et al.
Pageof 9

Showing results (51-60 of 82) with videos related to

Sort By:
Pageof 9
Thrombosis and Haemostasis|January 1, 1997
Factor VIII inhibitors in previously treated haemophilia A patients with a double virus-inactivated plasma derived factor VIII concentrateK Peerlinck, J Arnout, M Di Giambattista, et al.
Blood|December 1, 1994
Molecular basis for type 1 antithrombin deficiency: identification of two novel point mutations and evidence for a de novo splice site mutationK Jochmans, W Lissens, T Yin, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 10, 2017
Deficits of ankle muscle strength not found in children, adolescents and young adults with haemophilic ankle arthropathyS Lobet, J-L Croisier, A-C Lantin, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 24, 2016
Hepatitis G viral RNA in serum and in peripheral blood mononuclear cells and its relation to HCV-RNA in patients with clotting disordersL Sheng, A Soumillion, K Peerlinck, et al.
Journal of Thrombosis and Haemostasis : JTH|May 1, 2012
Antidote strategies to reverse anticoagulation with TB-402, a long-acting partial inhibitor of factor VIIIM Tangelder, C Long, J Emmerechts, et al.
British Journal of Haematology|March 1, 1992
A patient with von Willebrand's disease characterized by a compound heterozygosity for a substitution of Arg854 by Gln in the putative factor-VIII-binding domain of von Willebrand factor (vWF) on one allele and very low levels of mRNA from the second vWF alleleK Peerlinck, J C Eikenboom, H K Ploos Van Amstel, et al.
Thrombosis and Haemostasis|May 1, 1997
Hepatitis G viral RNA in serum and in peripheral blood mononuclear cells and its relation to HCV-RNA in patients with clotting disordersL Sheng, A Soumillion, K Peerlinck, et al.
Circulation|October 1, 1993
MK-383 (L-700,462), a selective nonpeptide platelet glycoprotein IIb/IIIa antagonist, is active in manK Peerlinck, I De Lepeleire, M Goldberg, et al.
International Journal of Laboratory Hematology|March 25, 2018
The adsorption of dabigatran is as efficient as addition of idarucizumab to neutralize the drug in routine coagulation assaysM Jacquemin, J Toelen, L Feyen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 5, 2013
Comparing normal saline versus diluted heparin to lock non-valved totally implantable venous access devices in cancer patients: a randomised, non-inferiority, open trialG A Goossens, M Jérôme, C Janssens, et al.
Pageof 9